Perspective Therapeutics (CATX) Receivables - Accured (2022 - 2024)
Historic Revenue - Other for Perspective Therapeutics (CATX) over the last 5 years, with Q3 2025 value amounting to $209000.0.
- Perspective Therapeutics' Receivables - Accured changed N/A to $880000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $880000.0, marking a year-over-year change of. This contributed to the annual value of $880000.0 for FY2024, which is N/A changed from last year.
- Per Perspective Therapeutics' latest filing, its Revenue - Other stood at $209000.0 for Q3 2025, which was down 4336.04% from $290000.0 recorded in Q2 2025.
- Over the past 5 years, Perspective Therapeutics' Receivables - Accured peaked at $880000.0 during Q4 2024, and registered a low of $109000.0 during Q4 2022.
- Over the past 3 years, Perspective Therapeutics' median Revenue - Other value was $325000.0 (recorded in 2024), while the average stood at $339000.0.
- Its Revenue - Other has fluctuated over the past 5 years, first soared by 3948.5% in 2024, then crashed by 4486.69% in 2025.
- Over the past 2 years, Perspective Therapeutics' Receivables - Accured (Quarter) stood at $109000.0 in 2022, then soared by 707.34% to $880000.0 in 2024.
- Its last three reported values are $209000.0 in Q3 2025, $290000.0 for Q2 2025, and $342000.0 during Q1 2025.